Fourpath Capital Management’s Lam Research LRCX Stock Holding History

Fourpath Capital Management’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-570	Closed	-$46.5K	–	533
2024 Q3	$46.5K	Buy	+570	New	+$49.6K	0.01%	349

Other funds holding LRCX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fourpath Capital Management's LRCX Position: Q4 2024 in Review

Fourpath Capital Management sold out of Lam Research (LRCX) in Q4 2024, closing a stake of 570 shares — an estimated $46.5K sold.

Fourpath Capital Management first reported a position in LRCX in Q3 2024 and held it in 1 quarter. The position peaked at $46.5K in Q3 2024. 1,690 funds tracked by Wall St. Rank hold LRCX as of Q4 2024.

Fourpath Capital Management reported no remaining Lam Research position as of Q4 2024 after selling out during the quarter.
Fourpath Capital Management sold 570 Lam Research shares in Q4 2024, an estimated $46.5K.
Fourpath Capital Management first reported a position in Lam Research in Q3 2024 and held it in 1 quarter.
Fourpath Capital Management's Lam Research position peaked at $46.5K in Q3 2024.
1,690 funds tracked by Wall St. Rank held Lam Research as of Q4 2024.

Based on Fourpath Capital Management's 13F filing for Q4 2024, filed 24 Jan 2025.